[Endolymphatic curietherapy by lymphography with labelled lipiodol in Hodgkin's disease. A report on 408 cases (author's transl)].
The results of 373 lymphography examinations with radioactive lipiodol, conducted in 408 patients with Hodgkin's disease for diagnostic and prophylactic therapeutic purposes, during investigations carried out from 1966 to 1973 are analyzed. Tolerance was always excellent, especially from the hematological point of view. The efficacy of the procedure can be assessed by the fact that there were only 6% of failures (21/373) in glandular regions irradiated in this way for prophylactic purposes. Relapses occur more frequently in the inguino-iliac and lumbo-aortic regions than in the pelvic chains which were perfectly protected. This technique also enables both pelvic irradiation and ovarian protection in young women without any risk of failure. The procedure is particularly indicated in the following cases: supradiaphragmatic stages I and II, whatever the sex, and stage III especially in women. In sub-diaphragmatic stages I and II, it allows, in favourable cases, the ovarian function in women to remain intact by limiting external irradiation to invaded regions only.
D001918:Brachytherapy; D005260:Female; D006689:Hodgkin Disease / Q000000981:diagnostic imaging / Q000532:radiotherapy*; D006801:Humans; D007459:Iodized Oil / Q000627:therapeutic use*; D008220:Lymphography / Q000009:adverse effects; D008297:Male; D010053:Ovary / Q000528:radiation effects; D011247:Pregnancy; D011835:Radiation Protection; D011879:Radiotherapy Dosage
D007459:Iodized Oil
La curiethérapie endolymphatique par lymphographie au lipiodol marqué dans la maladie de Hodgkin. 408 observations.